Sugammadex does not bind to plasma proteins. [19, 22, 28] When administered by itself in volunteers who had not received a neuromuscular blocking agent, doses of sugammadex 0.1-8.0 mg/kg had a ...

BR55 injection, an investigational contrast agent for ultrasounds, works by binding to vascular endothelial growth factor receptor 2 (VEGFR2), a protein involved in angiogenesis and inflammation.

Protier Biotech Inc. has patented protein/nucleic acid degraders comprising cereblon (CRBN)-binding agents covalently bound to a eukaryotic peptide chain release factor GTP-binding subunit ERF3A ...

Detailed price information for Briacell Therapeutics Corp WT (BCTXW-Q) from The Globe and Mail including charting and trades.